[HTML][HTML] Fates of CD8+ T cells in tumor microenvironment
NR Maimela, S Liu, Y Zhang - Computational and structural biotechnology …, 2019 - Elsevier
Studies have reported a positive correlation between elevated CD8+ T cells in the tumor
microenvironment (TME) and good prognosis in cancer. However, the mechanisms linking T …
microenvironment (TME) and good prognosis in cancer. However, the mechanisms linking T …
[HTML][HTML] Mutant isocitrate dehydrogenase inhibitors as targeted cancer therapeutics
The identification of heterozygous neomorphic isocitrate dehydrogenase (IDH) mutations
across multiple cancer types including both solid and hematologic malignancies has …
across multiple cancer types including both solid and hematologic malignancies has …
Overview of cancer stem cells and stemness for community oncologists
Advances in cancer research in the past have led to an evolving understanding of cancer
pathogenesis and the development of novel drugs that significantly improve patient …
pathogenesis and the development of novel drugs that significantly improve patient …
Cancer stem cells and their possible implications in cervical cancer: a short review
R Di Fiore, S Suleiman, R Drago-Ferrante… - International journal of …, 2022 - mdpi.com
Cervical cancer (CC) is the fourth most common type of gynecological malignancy affecting
females worldwide. Most CC cases are linked to infection with high-risk human …
females worldwide. Most CC cases are linked to infection with high-risk human …
The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia
H Zhao, H Zhu, J Huang, Y Zhu, M Hong, H Zhu… - Leukemia research, 2018 - Elsevier
Background Decitabine is widely used in the treatment of acute myeloid leukemia (AML) in
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
elderly patients. Low-dose Vitamin C has also been indicated to induce DNA demethylation …
Aberrant miRNA promoter methylation and EMT‐involving miRNAs in breast cancer metastasis: diagnosis and therapeutic implications
Breast cancer (BC) is the most prevalent cancer in women worldwide. Although extensive
studies are ongoing concerning its intricate molecular mechanisms, development of novel …
studies are ongoing concerning its intricate molecular mechanisms, development of novel …
DNMT1 inhibition reprograms pancreatic cancer stem cells via upregulation of the miR-17-92 cluster
Pancreatic ductal adenocarcinoma (PDAC) and other carcinomas are hierarchically
organized, with cancer stem cells (CSC) residing at the top of the hierarchy, where they drive …
organized, with cancer stem cells (CSC) residing at the top of the hierarchy, where they drive …
Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene expression
RS Seelan, P Mukhopadhyay, MM Pisano… - Drug metabolism …, 2018 - Taylor & Francis
Aza-2'-deoxycytidine (AzaD), also known as Decitabine, is a deoxycytidine analog that is
typically used to activate methylated and silenced genes by promoter demethylation …
typically used to activate methylated and silenced genes by promoter demethylation …
Cancer stem cells in prostate cancer: implications for targeted therapy
R Leão, C Domingos, A Figueiredo, R Hamilton… - Urologia …, 2017 - karger.com
Prostate cancer (PCa) is the most frequently diagnosed cancer in men and the second most
common cause of cancer-related mortality among men in the developed world …
common cause of cancer-related mortality among men in the developed world …